Le Lézard
Classified in: Science and technology, Business
Subjects: CON, PDT, JVN

Revolutionizing ServiceNow Solutions: xtype and NewRocket Forge Groundbreaking Partnership to Propel Customer Success and Efficiency


The partnership will see xtype empower NewRocket to improve customer satisfaction and deliver enhanced customer experiences.

COVINA, Calif., March 7, 2024 /PRNewswire/ -- xtype, a platform engineering startup, is today announcing its partnership with NewRocket, a global, full-service Elite ServiceNow partner. The partnership will see the organizations collaborating to help customers deliver value on ServiceNow faster, extending their combined reach to support and positively impact even more customers using the platform. The announcement is a testament to the xtype's upward trajectory in the ServiceNow global community and follows only shortly after xtype was awarded Build Platform Partner status on ServiceNow.

The collaboration envisions a transformative impact on the ServiceNow ecosystem, with xtype and NewRocket committing to a strategic alliance that will not only enhance their service offerings but will significantly accelerate project delivery, optimize customer satisfaction, and enables customers to realize the full potential of their investments more efficiently.

How xtype and NewRocket are enhancing value for ServiceNow customers:

Blaine Pryce, SVP of Sales at xtype, said of the partnership: "This partnership is a multifold win: for xtype, NewRocket, and most importantly, our ServiceNow customers, who will now see the value of their investments faster than ever. Together, we're accelerating project delivery and revolutionizing the quality and speed at which ServiceNow solutions are implemented, ensuring our customers reach their goals with unprecedented efficiency."

Through this partnership, xtype's innovative ServiceNow-native products will be combined with NewRocket's extensive expertise, with the partners promising to deliver unparalleled value, drive customer success, and set new standards in efficiency and effectiveness within the ServiceNow platform.

Andrew Paolino, Chief Strategy Officer of NewRocket, agreed saying, "Teaming up with xtype, we're setting a new standard in customer experience and efficiency, driving NewRocket's growth to new heights."

xtype will be attending the upcoming Knowledge 2024 event in Las Vegas, Nevada this May, and will be sharing more on their presence via xtype.io.

About xtype

Founded in 2020, xtype is a venture-backed startup reimagining the agile software delivery approach on the ServiceNow platform. The company offers an off-the-shelf option for customers to meet any level of demand on the ServiceNow platform and drive improved business outcomes at scale. xtype achieves this through its ServiceNow-native applications, enabling enterprises to expedite ServiceNow delivery and get more out of their ServiceNow investment - faster. To date, xtype has worked with organizations such as Zurich Insurance and Heineken, as well as large international banks and technology companies globally, and has achieved Build Platform Partner status.

www.xtype.io

Logo - https://mma.prnewswire.com/media/2355423/NewRocket_Logo.jpg
Logo - https://mma.prnewswire.com/media/2055507/xtype_Logo.jpg

SOURCE xtype


These press releases may also interest you

at 18:05
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 10:15
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

at 06:47
After tens of thousands of NYC children were turned away from "Summer Rising," New York City's popular, free summer enrichment program, Brains & Motion launched a campaign offering camps at NYU for a small fraction of the up-to-$1400 per week price...



News published on and distributed by: